Fidelity Investments’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-11
Closed -$22 5347
2025
Q1
$22 Buy
+11
New +$22 ﹤0.01% 5217
2024
Q3
Sell
-137,823
Closed -$2.82M 5503
2024
Q2
$2.82M Sell
137,823
-18,059
-12% -$370K ﹤0.01% 2257
2024
Q1
$7.03M Sell
155,882
-1,528
-1% -$68.9K ﹤0.01% 1979
2023
Q4
$7.43M Sell
157,410
-11,385
-7% -$537K ﹤0.01% 1949
2023
Q3
$6.83M Sell
168,795
-104,545
-38% -$4.23M ﹤0.01% 1949
2023
Q2
$29.1M Buy
273,340
+6,047
+2% +$644K ﹤0.01% 1480
2023
Q1
$79.8M Buy
267,293
+4,578
+2% +$1.37M 0.01% 1070
2022
Q4
$90.3M Buy
262,715
+363
+0.1% +$125K 0.01% 1010
2022
Q3
$49.6M Buy
262,352
+17
+0% +$3.22K 0.01% 1246
2022
Q2
$55.4M Buy
262,335
+2
+0% +$422 0.01% 1213
2022
Q1
$87.8M Buy
262,333
+17
+0% +$5.69K 0.01% 1126
2021
Q4
$85.3M Buy
262,316
+25,729
+11% +$8.37M 0.01% 1181
2021
Q3
$115M Buy
236,587
+41,911
+22% +$20.4M 0.01% 1041
2021
Q2
$90.5M Buy
194,676
+55,311
+40% +$25.7M 0.01% 1161
2021
Q1
$96.2M Buy
139,365
+14,241
+11% +$9.83M 0.01% 1078
2020
Q4
$92.5M Buy
125,124
+4,710
+4% +$3.48M 0.01% 1067
2020
Q3
$83.5M Buy
120,414
+109,958
+1,052% +$76.3M 0.01% 1001
2020
Q2
$8.87M Sell
10,456
-27,387
-72% -$23.2M ﹤0.01% 1860
2020
Q1
$13.5M Sell
37,843
-19,069
-34% -$6.82M ﹤0.01% 1581
2019
Q4
$13.3M Hold
56,912
﹤0.01% 1742
2019
Q3
$6.41M Buy
56,912
+12,738
+29% +$1.43M ﹤0.01% 1974
2019
Q2
$7.75M Sell
44,174
-8,404
-16% -$1.47M ﹤0.01% 1969
2019
Q1
$8.32M Sell
52,578
-1,243
-2% -$197K ﹤0.01% 1923
2018
Q4
$3.32M Sell
53,821
-28,575
-35% -$1.76M ﹤0.01% 2160
2018
Q3
$10.1M Sell
82,396
-21,771
-21% -$2.67M ﹤0.01% 1930
2018
Q2
$15.3M Hold
104,167
﹤0.01% 1811
2018
Q1
$17.1M Buy
+104,167
New +$17.1M ﹤0.01% 1785